Conference
Impact of clinical and molecular predictors of benefit from erlotinib in advanced non-small cell lung cancer on cost-effectiveness
Authors
Bradbury PA; Tu D; Seymour L; Ng R; Zhu L; Isogai PK; Mittmann N; Evans WK; Shepherd FA; Leighl NB
Volume
26
Pagination
pp. 6531-6531
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
May 20, 2008
DOI
10.1200/jco.2008.26.15_suppl.6531
Conference proceedings
Journal of Clinical Oncology
Issue
15_suppl
ISSN
0732-183X